RxDoctor Payments Data

Eric McClanahan

Internal Medicine · Bluefield, WVNPI 1619162237

Payments from drug & device makers

$2,195in general payments, 2019–2025

Across 134 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$506
  • Lilly USA, LLC$424
  • GSK$262
  • Amgen$229
  • Exact Sciences$156
  • AstraZeneca$108
  • plus $510 from 12 others

What the payments were for

  • Food & beverage$2,18099%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,195 in reported general payments places this provider in the 80th percentile of 573 internal medicine providers in West Virginia.

See all internal medicine providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide132$163,071
JardianceEmpagliflozin91$138,701
Humira PenAdalimumab14$99,824
JanuviaSitagliptin Phosphate55$78,599
EliquisApixaban78$77,349
FarxigaDapagliflozin Propanediol51$66,345
MounjaroTirzepatide61$64,417
TrulicityDulaglutide43$53,197
XifaxanRifaximin15$50,587
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$40,354
XareltoRivaroxaban38$35,758
Tresiba Flextouch U-200Insulin Degludec13$34,282
LinzessLinaclotide40$32,074
Repatha SureclickEvolocumab25$28,615
TradjentaLinagliptin31$28,573

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$506$174,377135 claims
Novo NordiskOzempic, Novolog$63$166,905143 claims
Lilly USA, LLCMounjaro, Trulicity$424$117,615104 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$108$107,35495 claims
MerckJanuvia, Dulera$39$93,43773 claims
PfizerEliquis$95$77,34978 claims
GSKTrelegy Ellipta, Breo Ellipta$262$50,65151 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$40$50,58715 claims
Johnson & JohnsonXarelto$14$35,75838 claims
AbbVieLinzess$60$32,07440 claims
NovartisEntresto$33$26,79025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 573 internal medicine providers in West Virginia.

Other internal medicine in Bluefield

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →